Hans van Houte
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | $545,833 | $2,296,503 |
| 2024 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | $498,675 | $2,016,482 |
| 2023 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | $482,925 | $1,611,987 |
| 2022 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | $465,417 | $4,307,781 |
| 2021 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | $413,750 | $1,659,957 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.